Cancer survivorship issues for minority and underserved populations.
Cancer Epidemiol. Biomarkers Prev., Mar;12(3):284s-286s (2003)
Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.
J. Clin. Oncol., Apr;23(12):2735-43 (2005)
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
Cancer Res., Feb;49(3):595-8 (1989)
A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.
J. Clin. Oncol., Jul;8(7):1239-45 (1990)
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.
J. Clin. Oncol., Jan;10(1):102-10 (1992)
High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.
J. Natl. Cancer Inst. Monographs., (16):91-4 (1994)
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
N. Engl. J. Med., Sep;319(10):593-8 (1988)
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.
J. Clin. Oncol., May;30(14):1715-24 (2012)
In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril.
J. Natl. Cancer Inst., Mar;95(5):388-99 (2003)
Cloning and characterization of the 5'-flanking sequence for the human DNA topoisomerase II beta gene.
Gene., Dec;203(2):113-9 (1997)
Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature.
Ann. Hematol., Apr;83(4):242-6 (2004)
ASCO Task Force on the Cost of Cancer Care.
J Oncol Pract., Sep;5(5):218-9 (2009)
Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline.
Cancer Chemother. Pharmacol., 26(6):423-8 (1990)
Viral infections and cancer.
Compr Ther., Mar;16(3):42-8 (1990)
A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients.
Cancer Chemother. Pharmacol., 29(1):61-5 (1991)
Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung.
Cancer., Feb;67(4):892-5 (1991)
Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens.
Bone Marrow Transplant., Jul;10(1):57-63 (1992)
Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapy.
Cancer., Feb;73(4):1276-85 (1994)
Attitudes and practices of U.S. oncologists regarding euthanasia and physician-assisted suicide.
Ann. Intern. Med., Oct;133(7):527-32 (2000)
SMARCAD1, a novel human helicase family-defining member associated with genetic instability: cloning, expression, and mapping to 4q22-q23, a band rich in breakpoints and deletion mutants involved in several human diseases.
Genomics., Oct;69(2):162-73 (2000)